Patient information session melanoma trials by Christian Blank11-07-2022
“Now I am sitting here, six years after participating in the first neoadjuvant trial, and hearing about all the results, I understand how important our role has been, and that feels good”.
In medical oncologist Christian Blank’s experience, patients who have participated in a clinical trial investigating neoadjuvant immunotherapy for melanoma would like to be informed about the results of these studies. They also appreciate being able to meet each other to discuss their experiences. That’s why Blank and his team have been inviting all patients who have participated in their trials to visit the Netherlands Cancer Institute for an information session followed by drinks. They hosted one of these sessions on Saturday, June 25 – the first in quite a long time due to COVID-19.